Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B

JAMA Oncol. 2019 Jun 1;5(6):915. doi: 10.1001/jamaoncol.2019.0644.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents*
  • Carcinoma, Hepatocellular*
  • Cohort Studies
  • Guanine / analogs & derivatives
  • Hepatitis B, Chronic*
  • Humans
  • Liver Neoplasms*
  • Republic of Korea
  • Tenofovir

Substances

  • Antiviral Agents
  • entecavir
  • Guanine
  • Tenofovir